Economy News Why Weight Loss Drugs Like Ozempic Are A Game Changer For The Global Economy

Ozempic is a serious drug with serious risks. Here’s what to know.

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are downsides—and potentially serious side effects. Read More

Ozempic is changing how we spend money and time, plus what we eat

Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Industry insiders are gearing up for weight-loss drugs to shake up the ... Read More

Weight-loss drugs are changing. Here’s what to know

Weight-loss drugs known as GLP-1s are transforming health care. Some people who struggled for years to shed pounds experience dramatic weight loss on the medications, and there are indications that ... Read More

Weight-loss drugs will go global

Drugs that treat diabetes and weight loss have become a commercial and cultural phenomenon. But supply shortages and eye-watering prices have kept slimming jabs largely confined to the rich world, ... Read More

How Novo Nordisk is trying to regain its weight-loss edge

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their ... Read More

U.S. regulators approve Wegovy pill for weight loss

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. Read More

WHO recommends Ozempic-style weight loss drugs for obesity

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease associated with substantial morbidity, mortality, and economic ... Read More

A second helping of weight-loss drugs is coming

The appetite for weight-loss drugs, known as glp-1 agonists, has been insatiable since they hit the market a decade ago. In 2024 global spending on them reached $54bn, a figure that is sure to rise in ... Read More

It's official: Global health body makes historic call on weight-loss drugs

The World Health Organization (WHO) has finally made its recommendations on using glucagon-like peptide-1 (GLP-1) therapeutics for weight loss, though it remains to be seen whether it changes their ... Read More

More Americans use weight loss drugs like Ozempic than live in Texas

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ... Read More